Volume 122, Issue 4 , Pages 697-699, October 2008
Asthma exacerbations: Putting a lid on the volcano
Key words: Asthma, asthma control, asthma impairment, asthma risk, asthma exacerbations
No abstract is available. To read the body of this article, please view the Full Text online.
Supported in part by Public Health Services Research Grants HR-16048, HL64288, HL 51834, AI-25496, HL081335, and HL075416; General Clinical Research Center Grant 5 MO1 RR00051; and the Colorado Cancer, Cardiovascular and Pulmonary Disease Program.
Disclosure of potential conflict of interest: S. J. Szefler has served as a consultant for AstraZeneca, GlaxoSmithKline, Aventis, Genentech, and Merck and has received research support from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) Childhood Asthma Management Program, NHLBI Childhood Asthma Research and Education, the NIH/NHLBI Asthma Clinical Research Network, the NIH/National Institute of Allergy and Infectious Diseases Inner-City Asthma Consortium, and Ross Pharmaceuticals.
PII: S0091-6749(08)01554-6
doi:10.1016/j.jaci.2008.08.022
© 2008 American Academy of Allergy, Asthma & Immunology. Published by Elsevier Inc. All rights reserved.
Volume 122, Issue 4 , Pages 697-699, October 2008
